Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hikma Pharmaceuticals Llc

Clinical trials sponsored by Hikma Pharmaceuticals Llc, explained in plain language.

Now part of Hikma Pharmaceuticals PLC HIK LONDON

Generic and specialty pharmaceutical manufacturer.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 1

Compassionate use study offers AML patients continued access to experimental oral chemo

Disease control Ongoing

This study gives a small group of adults with acute myeloid leukemia (AML) continued access to an oral form of the chemotherapy drug azacitidine after they finished a previous trial. The main goal is to track any side effects and see how safe the drug is over a longer period. Abo…

Phase: NA • Sponsor: Hikma Pharmaceuticals LLC • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC